Table 4.

Competing risk analysis for reversion to normoglycemia considering the competing risk of progression to diabetes

	SHR (95%CI)
	Model I	Model II	Model III
Reversion to normoglycemia
RC (per SD increase)	0.75 (0.73, 0.77)	0.81 (0.80, 0.84)	0.82 (0.80, 0.85)
P value	< 0.001	< 0.001	< 0.001
RC quartile
Q1	Ref	Ref	Ref
Q2	0.74 (0.69, 0.79)	0.83 (0.78, 0.89)	0.83 (0.77, 0.88)
Q3	0.59 (0.56, 0.64)	0.71 (0.66, 0.76)	0.72 (0.67, 0.77)
Q4	0.45 (0.43, 0.49)	0.58 (0.54, 0.63)	0.61 (0.56, 0.66)
P for trend	< 0.001	< 0.001	< 0.001

Abbreviations SHR subdistribution hazard ratios, CI confidence interval, Ref, reference

Model I was unadjusted

Model II adjusted for age, sex, family history of diabetes, smoking status, drinking status, SBP, DBP, and BMI

Model III adjusted for age, sex, family history of diabetes, smoking status, drinking status, SBP, DBP, BMI, FPG, TG, ALT, AST, HDL-C, LDL-C, BUN, and Cr